{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:14Z","timestamp":1787003654450,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ellison Foundation, United States"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Progressive secondary brain injury\u2014induced by dysregulated neuroinflammation in spontaneous intracerebral hemorrhage (sICH)\u2014underlies high sICH-mortality and remains without FDA-approved pharmacotherapy. Clinical insight that hematoma-directed interventions do not improve mortality prioritizes resolving acute secondary brain injury in sICH. As neutrophils are implicated in sICH secondary brain injury, we tested whether inhibition of a rogue neutrophil-subset expressing the dual endothelin-1\/signal peptide receptor (DEspR) and associated with secondary tissue injury, DEspR+ CD11b+ immunotype, will attenuate mortality in a hypertensive-sICH (hsICH) rat model. We confirmed sICH-related deaths in hsICH-rats by T2*-weighted 9.4\u00a0T MRI and DEspR+ neutrophils in hsICH-rat brain perihematomal areas by immunostaining. At acute sICH, anti-DEspR muIgG1-antibody, mu10a3, treatment increased median survival in hsICH rats\n                    <jats:italic>vs<\/jats:italic>\n                    controls (p\u2009&lt;\u20090.0001). In pre-stroke sICH, weekly 10a3-treatment did not predispose to infection and delayed sICH-onset\n                    <jats:italic>vs<\/jats:italic>\n                    controls (p\u2009&lt;\u20090.0001). As potential sICH-therapeutic, we tested humanized anti-DEspR IgG4\n                    <jats:sup>S228P<\/jats:sup>\n                    -mAb, hu6g8. In vitro, hu6g8 reversed delayed-apoptosis in DEspR+ CD11b+ neutrophils. In vivo, hu6g8 increased median survival and reduced neurologic symptoms in male\/female hsICH-rats\n                    <jats:italic>vs<\/jats:italic>\n                    controls (p\u2009&lt;\u20090.0001). Altogether, preclinical efficacy of inhibition of DEspR+ CD11b+ neutrophils in acute sICH\u2014without infection complications, supports the potential of anti-DEspR therapy in sICH. Data provide basis for clinical study of DEspR+ CD11b+ neutrophil-subset in sICH patients.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-28149-3","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T07:42:44Z","timestamp":1676965364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-DEspR antibody treatment improves survival and reduces neurologic deficits in a hypertensive, spontaneous intracerebral hemorrhage (hsICH) rat model"],"prefix":"10.1038","volume":"13","author":[{"given":"Victoria L. M.","family":"Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Gromisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius L.","family":"Decano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khristine Amber","family":"Pasion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glaiza L. A.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney E.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Ruiz-Opazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"28149_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5853\/jos.2016.00864","volume":"19","author":"SJ An","year":"2017","unstructured":"An, S. J., Kim, T. J. & Yoon, B. W. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: An update. J. Stroke 19, 3\u201310. https:\/\/doi.org\/10.5853\/jos.2016.00864 (2017).","journal-title":"J. Stroke"},{"key":"28149_CR2","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s12028-021-01311-3","volume":"35","author":"KN Kearns","year":"2021","unstructured":"Kearns, K. N. et al. Neuroprotective therapies for spontaneous intracerebral hemorrhage. Neurocrit. Care 35, 862\u2013886. https:\/\/doi.org\/10.1007\/s12028-021-01311-3 (2021).","journal-title":"Neurocrit. Care"},{"key":"28149_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1517\/14728214.12.3.389","volume":"12","author":"PA Lapchak","year":"2007","unstructured":"Lapchak, P. A. & Araujo, D. M. Advances in hemorrhagic stroke therapy: Conventional and novel approaches. Expert. Opin. Emerg. Drugs 12, 389\u2013406. https:\/\/doi.org\/10.1517\/14728214.12.3.389 (2007).","journal-title":"Expert. Opin. Emerg. Drugs"},{"key":"28149_CR4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(19)30195-3","volume":"393","author":"DF Hanley","year":"2019","unstructured":"Hanley, D. F. et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): A randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet 393, 1021\u20131032. https:\/\/doi.org\/10.1016\/S0140-6736(19)30195-3 (2019).","journal-title":"Lancet"},{"key":"28149_CR5","doi-asserted-by":"publisher","unstructured":"The Hemorrhagic Stroke Academia Industry (HEADS) Roundtable Participants. Basic and Translational Research in Intracerebral Hemorrhage: Limitations, Priorities, and Recommendations. Stroke 49, 1308\u20131314. https:\/\/doi.org\/10.1161\/STROKEAHA.117.019539 (2018).","DOI":"10.1161\/STROKEAHA.117.019539"},{"key":"28149_CR6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/acn3.50842","volume":"6","author":"A Shtaya","year":"2019","unstructured":"Shtaya, A. et al. Rapid neuroinflammatory changes in human acute intracerebral hemorrhage. Ann. Clin. Transl. Neurol. 6, 1465\u20131479. https:\/\/doi.org\/10.1002\/acn3.50842 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"28149_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12640-018-9890-6","volume":"34","author":"F Wang","year":"2018","unstructured":"Wang, F. et al. Neutrophil-to-lymphocyte ratio is an independent predictor of 30-day mortality of intracerebral hemorrhage patients: A validation cohort study. Neurotox. Res. 34, 347\u2013352. https:\/\/doi.org\/10.1007\/s12640-018-9890-6 (2018).","journal-title":"Neurotox. Res."},{"key":"28149_CR8","doi-asserted-by":"publisher","first-page":"106339","DOI":"10.1016\/j.clineuro.2020.106339","volume":"200","author":"G Menon","year":"2021","unstructured":"Menon, G. et al. Neutrophil to lymphocyte ratio\u2014A novel prognostic marker following spontaneous intracerebral haemorrhage. Clin. Neurol. Neurosurg. 200, 106339. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106339 (2021).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"28149_CR9","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2016-01-688887","volume":"127","author":"C Silvestre-Roig","year":"2016","unstructured":"Silvestre-Roig, C., Hidalgo, A. & Soehnlein, O. Neutrophil heterogeneity: Implications for homeostasis and pathogenesis. Blood 127, 2173\u20132181. https:\/\/doi.org\/10.1182\/blood-2016-01-688887 (2016).","journal-title":"Blood"},{"key":"28149_CR10","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/biom11081123","volume":"11","author":"WC Ziai","year":"2021","unstructured":"Ziai, W. C. et al. Early inflammatory cytokine expression in cerebrospinal fluid of patients with spontaneous intraventricular hemorrhage. Biomolecules 11, 1123. https:\/\/doi.org\/10.3390\/biom11081123 (2021).","journal-title":"Biomolecules"},{"key":"28149_CR11","doi-asserted-by":"publisher","first-page":"104861","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104861","volume":"29","author":"M M\u00fcller","year":"2020","unstructured":"M\u00fcller, M., Tapia-Perez, J. H., Yildiz, C., Rashidi, A. & Luchtmann, M. Alterations in inflammatory markers and clinical outcome after spontaneous intracerebral hemorrhage - Preliminary results. J. Stroke Cerebrovasc. Dis. 29, 104861. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104861 (2020).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"28149_CR12","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1038\/s41598-022-09343-1","volume":"12","author":"VLM Herrera","year":"2022","unstructured":"Herrera, V. L. M. et al. A targetable \u2018rogue\u2019 neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS. Sci. Rep. 12, 5583. https:\/\/doi.org\/10.1038\/s41598-022-09343-1 (2022).","journal-title":"Sci. Rep."},{"key":"28149_CR13","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s11307-010-0444-4","volume":"13","author":"JL Decano","year":"2011","unstructured":"Decano, J. L., Moran, A. M., Ruiz-Opazo, N. & Herrera, V. L. Molecular imaging of vasa vasorum neovascularization via DEspR-targeted contrast-enhanced ultrasound micro-imaging in transgenic atherosclerosis rat model. Mol. Imaging Biol. 13, 1096\u20131106. https:\/\/doi.org\/10.1007\/s11307-010-0444-4 (2011).","journal-title":"Mol. Imaging Biol."},{"key":"28149_CR14","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.108.833327","volume":"119","author":"JL Decano","year":"2009","unstructured":"Decano, J. L. et al. Early-life sodium exposure unmasks susceptibility to stroke in hyperlipidemic, hypertensive heterozygous Tg25 rats transgenic for human cholesteryl ester transfer protein. Circulation 119, 1501\u20131509. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.833327 (2009).","journal-title":"Circulation"},{"key":"28149_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2119\/molmed.2010.00228","volume":"17","author":"A Bergerat","year":"2011","unstructured":"Bergerat, A. et al. Prestroke proteomic changes in cerebral microvessels in stroke-prone, transgenic[hCETP]-Hyperlipidemic Dahl salt-sensitive hypertensive rats. Mol. Med. 17, 588\u2013598. https:\/\/doi.org\/10.2119\/molmed.2010.00228 (2011).","journal-title":"Mol. Med."},{"key":"28149_CR16","doi-asserted-by":"publisher","first-page":"e55222","DOI":"10.1371\/journal.pone.0055222","volume":"8","author":"JL Decano","year":"2013","unstructured":"Decano, J. L. et al. Analysis of CD45- [CD34+\/KDR+] endothelial progenitor cells as juvenile protective factors in a rat model of ischemic-hemorrhagic stroke. PLoS ONE 8, e55222. https:\/\/doi.org\/10.1371\/journal.pone.0055222 (2013).","journal-title":"PLoS ONE"},{"key":"28149_CR17","doi-asserted-by":"publisher","unstructured":"Herrera, V.L. et al. DespR roles in tumor vasculo-angiogenesis, invasiveness, CSC-survival and anoikis resistance: A \u2018common receptor coordinator\u2019 paradigm. PloS One 9, e85821. https:\/\/doi.org\/10.1371\/journal.pone.0085821. Erratum in: PloS One. 2014;9(10):e112335 (2014).","DOI":"10.1371\/journal.pone.0085821"},{"key":"28149_CR18","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1172\/JCI3868","volume":"102","author":"VL Herrera","year":"1998","unstructured":"Herrera, V. L., Xie, H. X., Lopez, L. V., Schork, N. J. & Ruiz-Opazo, N. The alpha1 Na, K-ATPase gene is a susceptibility hypertension gene in the Dahl salt-sensitiveHSD rat. J. Clin. Invest. 102, 1102\u20131111. https:\/\/doi.org\/10.1172\/JCI3868 (1998).","journal-title":"J. Clin. Invest."},{"key":"28149_CR19","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41598-018-37419-4","volume":"9","author":"H Kubotera","year":"2019","unstructured":"Kubotera, H. et al. Astrocytic endfeet re-cover blood vessels after removal by laser ablation. Sci. Rep. 9, 1263. https:\/\/doi.org\/10.1038\/s41598-018-37419-4 (2019).","journal-title":"Sci. Rep."},{"key":"28149_CR20","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/glia.22575","volume":"61","author":"JI Alvarez","year":"2013","unstructured":"Alvarez, J. I., Katayama, T. & Prat, A. Glial influence on the blood brain barrier. Glia 61, 1939\u20131958. https:\/\/doi.org\/10.1002\/glia.22575 (2013).","journal-title":"Glia"},{"key":"28149_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12885-021-08107-w","volume":"21","author":"CM Gromisch","year":"2021","unstructured":"Gromisch, C. M. et al. Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu\/nu model. BMC Cancer 21, 407. https:\/\/doi.org\/10.1186\/s12885-021-08107-w (2021).","journal-title":"BMC Cancer"},{"key":"28149_CR22","doi-asserted-by":"publisher","first-page":"104585","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104585","volume":"29","author":"K Miki","year":"2020","unstructured":"Miki, K. et al. Absence of microbleeds reduces the risk for recurrent intracerebral hemorrhage. J. Stroke Cerebrovasc. Dis. 29, 104585. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2019.104585 (2020).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"28149_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/STROKEAHA.110.590646","volume":"42","author":"C Venkatasubramanian","year":"2011","unstructured":"Venkatasubramanian, C. et al. Natural history of perihematomal edema after intracerebral hemorrhage measured by serial magnetic resonance imaging. Stroke 42, 73\u201380. https:\/\/doi.org\/10.1161\/STROKEAHA.110.590646 (2011).","journal-title":"Stroke"},{"key":"28149_CR24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1161\/STROKEAHA.114.007154","volume":"46","author":"J Yang","year":"2015","unstructured":"Yang, J. et al. Prognostic significance of perihematomal edema in acute intracerebral hemorrhage: Pooled analysis from the intensive blood pressure reduction in acute cerebral hemorrhage trial studies. Stroke 46, 1009\u20131013. https:\/\/doi.org\/10.1161\/STROKEAHA.114.007154 (2015).","journal-title":"Stroke"},{"key":"28149_CR25","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1161\/STROKEAHA.110.594457","volume":"41","author":"CL MacLellan","year":"2010","unstructured":"MacLellan, C. L., Silasi, G., Auriat, A. M. & Colbourne, F. Rodent models of intracerebral hemorrhage. Stroke 41, S95\u2013S98. https:\/\/doi.org\/10.1161\/STROKEAHA.110.594457 (2010).","journal-title":"Stroke"},{"key":"28149_CR26","doi-asserted-by":"publisher","unstructured":"Zhu, W. et al. Changes in motor function, cognition, and emotion-related behavior after right hemispheric intracerebral hemorrhage in various brain regions of mouse. Brain. Behav. Immun. 69, 568\u2013581. doi: https:\/\/doi.org\/10.1016\/j.bbi.2018.02.004 (2018). Erratum in: Brain Behav Immun. 2022 Jan;99:409\u2013411.","DOI":"10.1016\/j.bbi.2018.02.004"},{"key":"28149_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clineuro.2014.11.013","volume":"129","author":"S Grupke","year":"2015","unstructured":"Grupke, S., Hall, J., Dobbs, M., Bix, G. J. & Fraser, J. F. Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: From review to preview. Clin. Neurol. Neurosurg. 129, 1\u20139. https:\/\/doi.org\/10.1016\/j.clineuro.2014.11.013 (2015).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"28149_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/exnr.1998.6876","volume":"153","author":"MA Yenari","year":"1998","unstructured":"Yenari, M. A. et al. Hu23F2G, an antibody recognizing the leukocyte CD11\/CD18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia. Exp. Neurol. 153, 223\u2013233. https:\/\/doi.org\/10.1006\/exnr.1998.6876 (1998).","journal-title":"Exp. Neurol."},{"key":"28149_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fimmu.2013.00060","volume":"4","author":"D El Kebir","year":"2013","unstructured":"El Kebir, D. & Filep, J. G. Modulation of Neutrophil Apoptosis and the Resolution of Inflammation through \u03b22 Integrins. Front. Immunol. 4, 60. https:\/\/doi.org\/10.3389\/fimmu.2013.00060 (2013).","journal-title":"Front. Immunol."},{"key":"28149_CR30","doi-asserted-by":"publisher","first-page":"e0193970","DOI":"10.1371\/journal.pone.0193970","volume":"13","author":"J Neumann","year":"2018","unstructured":"Neumann, J. et al. Beware the intruder: Real time observation of infiltrated neutrophils and neutrophil-Microglia interaction during stroke in vivo. PLoS ONE 13, e0193970. https:\/\/doi.org\/10.1371\/journal.pone.0193970 (2018).","journal-title":"PLoS ONE"},{"key":"28149_CR31","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/cns.13899","volume":"28","author":"F Yu","year":"2022","unstructured":"Yu, F. et al. Phagocytic microglia and macrophages in brain injury and repair. CNS Neurosci. Ther. 28, 1279\u20131293. https:\/\/doi.org\/10.1111\/cns.13899 (2022).","journal-title":"CNS Neurosci. Ther."},{"key":"28149_CR32","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.expneurol.2009.07.018","volume":"219","author":"AF Ducruet","year":"2009","unstructured":"Ducruet, A. F. et al. The complement cascade as a therapeutic target in intracerebral hemorrhage. Exp. Neurol. 219, 398\u2013403. https:\/\/doi.org\/10.1016\/j.expneurol.2009.07.018 (2009).","journal-title":"Exp. Neurol."},{"key":"28149_CR33","doi-asserted-by":"publisher","first-page":"113654","DOI":"10.1016\/j.expneurol.2021.113654","volume":"340","author":"K Holste","year":"2021","unstructured":"Holste, K. et al. The role of complement in brain injury following intracerebral hemorrhage: A review. Exp. Neurol. 340, 113654. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113654 (2021).","journal-title":"Exp. Neurol."},{"key":"28149_CR34","doi-asserted-by":"publisher","unstructured":"Hemorrhagic Stroke Academia Industry (HEADS) Roundtable Participants. Recommendations for Clinical Trials in ICH: The Second Hemorrhagic Stroke Academia Industry Roundtable. Stroke 51, 1333\u20131338. https:\/\/doi.org\/10.1161\/strokeaha.119.027882 (2020).","DOI":"10.1161\/strokeaha.119.027882"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28149-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28149-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28149-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T07:42:49Z","timestamp":1676965369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28149-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["28149"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-28149-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"assertion":[{"value":"3 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"VLMH and NRO: co-inventors on BU patents on DEspR and DEspR-inhibition for stroke therapy. All other authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2703"}}